Pharma Market Size, Share, Growth, and Industry Growth by Type (Prescription-Based Drugs and Over-The-Counter Drugs) By Application (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, and Others) Regional Forecast To 2033

PHARMA MARKET OVERVIEW

• 

  Request a Free sample to learn more about this report

The global Pharma Market stood at USD 484 billion in 2024 and is expected to rise to USD 541.11 billion in 2025, maintaining a strong growth trajectory to reach USD 1320.75 billion by 2033, with a CAGR of 11.8% from 2025 to 2033.

The global COVID-19 pandemic has been unprecedented and staggering, with pharma experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels.  The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Pharma industry develops, discovers, and produces pharmaceutical drugs which is use for medication purpose. The medicines aim to cure diseases.

A rise in demand for drug and increased prevalence of disease globally is estimated to drive market growth. Growing R&D activities coupled with mergers & acquisition in the pharmaceutical sector is anticipated to fuel market growth. Increased investment by market players and single-use disposable solution is predicted to fuel market progress. Increased adoption of artificial intelligence (AI) and rapid adoption of open transfer manufacturing techniques are predicted to fuel market progress. Further, increased prevalence of chronic condition such as diabetes, cancer, and other dieses. Growing number of disease and increased awareness about women healthcare is estimated to fuel market growth in the forthcoming years. On the contrary, fluctuation of raw materials prices to harm market growth in the coming years. Further, high demand for several clinical test to approve is anticipated to restrict market progress.

COVID-19 IMPACT

Increased Need for Vaccines & Medicines to Fuel Market Growth 

The global COVID-19 pandemic affected several businesses in 2020. Pharma market witnessed a positive growth due to high demand for vaccines and coronavirus medicines. Increased number of clinical trial activities and growing healthcare investment to surge market growth. Huge R&D investment and growing sales of drugs & vaccines coupled with high prioritized to treat respiratory diseases expand market growth.

On the contrary, lockdown restrictions hampered supply and chain and distribution.  

LATEST TRENDS

Increased R&D Activities among Pharmaceutical Companies to Fuel Market Growth

Increased R&D activities in the pharmaceutical companies and growing geriatric population is estimated to surge market progress. Huge demand to treat diseases and advanced research methods and clinically tested medicines are predicted to fuel market progress. Increased investment by market players and single-use disposable solution is predicted to fuel market progress. Increased adoption of artificial intelligence (AI) and rapid adoption of open transfer manufacturing techniques are predicted to fuel market progress. Further, increased prevalence of chronic condition such as diabetes, cancer, and other dieses. Growing number of disease and increased awareness about women healthcare is estimated to fuel market growth in the forthcoming years.

PHARMA MARKET SEGMENTATION

Request a Free sample to learn more about this report

By Type

Based on type, the market is divided into prescription-based drugs and over-the-counter drugs.

Prescription-based drugs are expected to be the top part of the segmentation type.

By Application

Based on the application, the market is divided into hospital pharmacies, retail pharmacies/ drug stores, and others.

Retail pharmacies/ drug stores are expected to be the top part of application segmentation.

DRIVING FACTORS

Adoption of New Technology and High Demand for Prescription-Based Drugs to Stimulate Market Growth

Huge adoption of new technology in the healthcare sector and high demand for prescription-based drugs is estimated to fuel market growth. Increasing number of patients prefer to have doctor prescribed drugs and rise in demand for drugs to cure diseases are anticipated to surge market growth. Growing awareness and prevalence of chronic diseases such as diabetes, cancer, and others and huge availability of treatment options is estimated to foster market growth in the forthcoming years. Increased patient population globally is projected to boost market growth. High concern to treat cardiovascular diseases is anticipated to surge market growth.

Government Regulations and Easy Availability of Medicines to Foster Market Growth

Increased government regulation to develop cost-effective medicines. Increased investment by government to develop new products and increased number of hospitalizations is predicted to fuel market growth. Increased adoption of medicines to treat disease is anticipated to fuel market growth. Huge technological advancements in drug development process and huge customer base is predicted to drive market growth in the forthcoming years.

RESTRAINING FACTORS

Fluctuation of Raw Material Prices to Harm Market Growth

Fluctuation of raw materials prices to harm market growth in the coming years. Further, high demand for several clinical test to approve is anticipated to restrict market progress.

PHARMA MARKET REGIONAL INSIGHTS

• Request a Free sample to learn more about this report

•  

Large Number of Strategic Pharma Partnerships in North America to Drive Market Share

North America is estimated to dominate pharma market share owing to large number of strategic pharma partnerships and rise in disease incidence. Huge customer base in the region and well-established companies are estimated to drive market growth. Adoption of new technology and a rise in demand for drug and increased prevalence of disease globally is estimated to drive market growth. Growing R&D activities coupled with mergers & acquisition in the pharmaceutical sector is anticipated to fuel market growth.

Asia Pacific is anticipated to account for second-largest position due to adoption of new technologies. Increased investment by market players and single-use disposable solution is predicted to fuel market progress. Increased adoption of artificial intelligence (AI) and rapid adoption of open transfer manufacturing techniques are predicted to fuel market progress. Further, increased prevalence of chronic condition such as diabetes, cancer, and other dieses. These factors are estimated to fuel market growth in the forthcoming years.  

KEY INDUSTRY PLAYERS

Leading Players Adopt New Strategies to Stay Competitive

The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

List of Top Pharma Companies

• Merck (U.S.)
• Sanofi (France)
• GlaxoSmithKline (U.K.)
• AbbVie (U.S.)
• Abbott Laboratories (U.S.)
• Novartis (Switzerland)
• Johnson & Johnson (U.S.)
• Hoffmann-La Roche (Switzerland)
• Mopson Pharmaceutical Limited (Nigeria)
• Merck & Co. (U.S.)
• Pfizer (U.S.)
• Zolon Healthcare Limited (Nigeria)
• Bayer (Germany)
• Sanofi Nigeria (Nigeria)
• Sun Pharma (India)

REPORT COVERAGE

This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.